Antares Pharma, Inc. (ATRS)

Income Tax Expense

$12.29M

TTM · Period ending: · USD

ATRS logo

ATRS Income Tax Expense

Latest reported$12.29M
ATRS TTM Income Tax ($1.40M → $12.29M)
High-resolution chart · PNG

ATRS income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
12,289,000
13,696,000
-45,005,000
-46,833,000
-45,690,000
-46,280,000
0
0
0
0
0
0
45,000
102,000
102,000
102,000
57,000
29,926
129,926
145,388
136,173
158,313
233,313
247,377
256,592
158,815
8,815
-33,548
-40,120
19,330
6,393
28,453
62,439
43,541
64,422
40,174
-3,775
1,384
-77,835
-62,810
-46,275
-46,275
-80,228
-57,217
-63,817
-63,817
95,225
330,037
467,676
465,944
402,956
127,027
6,254
39,842
11,382
26,845
226,187
197,230
90,238
59,683
-150,099
-171,755
-42,153
-23,606
-27,336
-3,086
-41,213
-32,675
-38,381
46,835
-35,339
-20,332,785
-22,012,272
-22,852,530
-22,105,870
-1,802,311
-123,471
638,769
7,214
10,138
20,395
23,884
19,104
16,180
16,180
0
0
0
0
0
0
0
100,000
0
0
-100,000
-200,000
-100,000
-100,000
600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.